Nanoparticles: Pushed off target with proteins.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Nature Nanotechnology

• Publication date

  2013-02-01

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1038/nnano.2013.11PMID 23380930
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface.

  2013cited by this paper
• Liposomal drug delivery systems: from concept to clinical applications.

  2013cited by this paper
• The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo.

  2013cited by this paper
• Immunoconjugates and long circulating systems: origins, current state of the art and future directions.

  2013cited by this paper
• Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: opportunities and challenges.

  2012cited by this paper
• Nanomedicine(s) under the microscope.

  2011cited by this paper
• Targeting of drugs and nanoparticles to tumors

  2010cited by this paper
• Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles

  2007cited by this paper
• Delivery of molecular and cellular medicine to solid tumors.

  1997cited by this paper

• Formulation optimization and characterization of Central composite design optimized LAP-loaded calcium pectinate nanoparticles: anticancer activity against MCF-7 cells

  2025cites this paper
• Modeling Absorption Dynamics of Differently Shaped Gold Glioblastoma and Colon Cells Based on Refractive Index Distribution in Holotomographic Imaging.

  2024cites this paper
• Copper Nanoclusters as Novel Podium for Cancer Detection, Imaging, and Therapy Applications.

  2024cites this paper
• CXCR4‐Expressing Mesenchymal Stem Cells Derived Nanovesicles for Rheumatoid Arthritis Treatment

  2023cites this paper
• Functionalized Gold Nanoclusters Promote Stress Response in COS‐7 Cells

  2023cites this paper
• Evidence of protein coronas around soft nanoparticles regardless of the chemical nature of the outer surface: structural features and biological consequences.

  2021cites this paper
• Application of nanoparticles in cancer therapy with an emphasis on cell cycle

  2021cites this paper
• Assessing and reconditioning kidneys using normothermic machine perfusion

  2021cites this paper
• Disulfide Bond Reversible Strategy Enables GSH Responsive‐Transferrin Nanoparticles for Precise Chemotherapy

  2020cites this paper
• Interactions at the cell membrane and pathways of internalization of nano-sized materials for nanomedicine

  2020cites this paper
• Understanding the Factors Influencing Chitosan-Based Nanoparticles-Protein Corona Interaction and Drug Delivery Applications

  2020cites this paper
• Probing protein adsorption onto polymer-stabilized silver nanocolloids towards a better understanding on the evolution and consequences of biomolecular coronas.

  2020cites this paper
• Polyglycidol-Stabilized Nanoparticles as a Promising Alternative to Nanoparticle PEGylation: Polymer Synthesis and Protein Fouling Considerations.

  2020cites this paper
• Impact of the protein corona on nanomaterial immune response and targeting ability.

  2020cites this paper
• The future of marginal kidney repair in the context of normothermic machine perfusion

  2018cites this paper
• Nanoparticles in Daily Life: Applications, Toxicity and Regulations.

  2018cites this paper
• The impact of protein corona on the behavior and targeting capability of nanoparticle‐based delivery system

  2018cites this paper
• Noncompetitive Active Transport Exploiting Intestinal Transferrin Receptors for Oral Delivery of Proteins by Tunable Nanoplatform.

  2017cites this paper
• IgA and IgM protein primarily drive plasma corona‐induced adhesion reduction of PLGA nanoparticles in human blood flow

  2017cites this paper
• Intracellular Accumulation of Gold Nanoparticles Leads to Inhibition of Macropinocytosis to Reduce the Endoplasmic Reticulum Stress

  2017cites this paper
• Synthesis and characterization of redox-sensitive heparin-β-sitosterol micelles: Their application as carriers for the pharmaceutical agent, doxorubicin, and investigation of their antimetastatic activities in vitro.

  2017cites this paper
• A pH-sensitive micelle composed of heparin, phospholipids, and histidine as the carrier of photosensitizers: Application to enhance photodynamic therapy of cancer.

  2017cites this paper
• Influence of dynamic flow environment on nanoparticle-protein corona: From protein patterns to uptake in cancer cells.

  2017cites this paper
• Regulatory Development of Nanotechnology-Based Vaccines

  2017cites this paper
• Algorithm-driven high-throughput screening of colloidal nanoparticles under simulated physiological and therapeutic conditions.

  2017cites this paper
• Organic Nanocarriers for the Delivery of Antiinfective Agents

  2017cites this paper
• Long-range interactions between protein-coated particles and POEGMA brush layers in a serum environment.

  2017cites this paper
• The Next Generation Non-competitive Active Polyester Nanosystems for Transferrin Receptor-mediated Peroral Transport Utilizing Gambogic Acid as a Ligand

  2016cites this paper
• Synthesis of the Nontargeted Nanoconstructs Stabilized with DTDTPA or TDOTA and the Respective Peptide Conjugated and / or Radiolabeled Particles Bioconjugate Chemistry

  2016cites this paper
• Cellular Response of Therapeutic Nanoparticles

  2016cites this paper
• Nanomedicine Activities in the United States and Worldwide

  2016cites this paper
• Interrogating the Role of Receptor-Mediated Mechanisms: Biological Fate of Peptide-Functionalized Radiolabeled Gold Nanoparticles in Tumor Mice.

  2016cites this paper
• Exploitation of nanoparticle-protein corona for emerging therapeutic and diagnostic applications.

  2016cites this paper
• Intracellular sorting of differently charged chitosan derivatives and chitosan-based nanoparticles.

  2015cites this paper
• Kohlenhydrat‐basierte Nanocarrier mit spezifischem Zell‐Targeting und minimalem Einfluss durch die Proteinkorona

  2015cites this paper
• Carbohydrate-Based Nanocarriers Exhibiting Specific Cell Targeting with Minimum Influence from the Protein Corona.

  2015cites this paper
• A new targeting agent for the selective drug delivery of nanocarriers for treating neuroblastoma.

  2015cites this paper
• Liposome-protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicines.

  2015cites this paper
• Advances in Nanotechnology-Based Drug Delivery Platforms and Novel Drug Delivery Systems

  2015cites this paper
• Regulatory aspects on nanomedicines.

  2015cites this paper
• TARGETING BREAST CANCER WITH BACTERIOPHAGE ASSOCIATED SILICON PARTICLES

  2014cites this paper
• Shrinkage of pegylated and non-pegylated liposomes in serum.

  2014cites this paper
• Understanding the structural parameters of biocompatible nanoparticles dictating protein fouling.

  2014cites this paper
• Binding of cytoskeletal proteins with silver nanoparticles

  2013cites this paper
• Nanoparticles targeting mechanisms in cancer therapy; great efforts, less implementations.

  2013cites this paper
• Bacteriophage Associated Silicon Particles: Design and Characterization of a Novel Theranostic Vector with Improved Payload Carrying Potential.

  2013cites this paper
• Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions.

  2013cites this paper
• Metaphors in Nanomedicine: The Case of Targeted Drug Delivery

  2013cites this paper